Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on May 29, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Compound Distribution Kits Supply

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412
New
Federal
SNS Pharmaceutical Logistic Replenishment Requirement
Solicitation # 75A50326R00007
The Department of Health and Human Services, through the Administration for Strategic Preparedness and Response, is soliciting proposals under solicitation 75A50326R00007 for the replenishment of expired or expiring pharmaceuticals for the Strategic National Stockpile. This is a full and open competition resulting in a twelve-month Firm Fixed Price contract. The scope includes the procurement of various FDA-approved pharmaceuticals, such as Dopamine Hydrochloride, Norepinephrine, and Morphine Sulfate, with the government reserving the right to increase awarded quantities by up to 20 percent. Deliveries are FOB Destination and may be required at up to nine locations across the contiguous United States and Hawaii. Award decisions will be based on a best-value tradeoff, prioritizing technical capability and past performance significantly over price. Technical evaluation focuses on product compliance, regulatory requirements, and the ability to meet delivery schedules. Strict quality standards are mandated, including adherence to current Good Manufacturing Practice regulations, specific temperature controls between 20C and 25C during storage and transit, and a requirement that products retain at least 90 percent of their FDA-approved shelf life upon receipt. Proposals must be submitted in two volumes by September 18, 2026, including a technical volume, a pricing volume, and a proposal submission worksheet. Large businesses are additionally required to submit subcontracting plans via the SBCX system.
Aspr/orm-Sns

POSTED

1 day ago

DEADLINE

in 6 days

AI Contract Overview

Show more

The contract involves the supply of Compound Distribution Kits designed to be compatible with Emulate platforms, intended for research use. These kits must adhere to established quality and documentation standards to ensure reliability and consistency in scientific applications. The solicitation for this subcontract was posted on May 29, 2026, with a response deadline set for June 12, 2026. The procurement falls under the NAICS code 325412, which corresponds to pharmaceutical preparation manufacturing, and is managed by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services. Specific details about the place of performance, organization type, and point of contact have not been provided. The contract aims to support research initiatives by providing essential supplies that integrate seamlessly with Emulate technology platforms.

General Info

Supply of Compound Distribution Kits for Emulate platforms, ensuring quality for research use.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

MD, USA

Set-Aside

NONE

Documents

This scope was carved out of FDA-CDER-OTS-26-RFI-A430.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Chip-S1 Basic Research Kits, Compound Distribution Kits, and MPS Consumables

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply of Compound Distribution Kits compatible with Emulate platforms, meeting quality and documentation standards for research use.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research is seeking a firm-fixed-price purchase order for human induced pluripotent stem cell-derived hindbrain organoid functional assay services. The contract involves the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to evaluate electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. This is a commercial service acquisition under FAR Part 12, intended as a sole-source award to OrganoTherapeutics SARL based on market research identifying them as the only source capable of meeting the full requirement. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS